Karin Nørby
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Karin Nørby has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Vibe Beltoft
Address
4 shared publications- Anoop Kumar Sharma
Research Group for Chemical Risk Assessment and GMO, Technical University of Denmark, National Food Institute, Lyngby, Denmark
2 shared publications - Elsa Nielsen
Division of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of Denmark, Kgs. Lyngby, DK-2800, Denmark
2 shared publications - Lea Bredsdorff
Technical University of Denmark, National Food Institute, Mørkhøj Bygade 19, DK-2860 Søborg, Denmark
2 shared publications National Food Institute
2 shared publications- Paul Michael Finglas
Quadram Institute Bioscience, Norwich, Norfolk NR4 7UQ, UK
2 shared publications
Latest Publications
- Open Access
- 1 February 2019
- Published by Wiley in EFSA Supporting Publications
- Vol. 16 (2)
Annual Report of preparatory work on the toxicological studies and animal feeding studies performed under the EFSA contract OC/EFSA/GMO/2014/01, Lot 2 during the period 1/3/2017 to 27/11/2018
- 1 February 2019
- Published by Wiley in EFSA Supporting Publications
- Vol. 16 (2)
Open AccessAnnual Report of preparatory work on the toxicological studies and animal feeding studies performed under the EFSA contract OC/EFSA/GMO/2014/01, Lot 2 during the period 1/3/2017 to 27/11/2018
- 1 February 2018
- Published by Wiley in EFSA Supporting Publications
- Vol. 15 (2)
Extensive literature search for studies related to fumonisins and their modified forms
- 1 February 2018
- Published by Wiley in EFSA Supporting Publications
- Vol. 15 (2)
Extensive literature search for studies related to fumonisins and their modified forms
- Open Access
- 1 October 2017
- Published by Wiley in EFSA Supporting Publications
- Vol. 14 (10)
Identifying and collecting relevant literature related to the oral toxicity of furan and its methyl analogues, 2-methylfuran and 3-methylfuran
- 1 October 2017
- Published by Wiley in EFSA Supporting Publications
- Vol. 14 (10)
Open AccessIdentifying and collecting relevant literature related to the oral toxicity of furan and its methyl analogues, 2-methylfuran and 3-methylfuran
- 4 September 2016
- Published by Elsevier in Toxicology Letters
- Vol. 258, S162
Safety assessment of chemically defined flavouring substances
- 4 September 2016
- Published by Elsevier in Toxicology Letters
- Vol. 258, S162
Safety assessment of chemically defined flavouring substances
- 1 February 2016
- Published by Elsevier in Food Chemistry
- Vol. 193, 121-127
ePlantLIBRA: A composition and biological activity database for bioactive compounds in plant food supplements
- 1 February 2016
- Published by Elsevier in Food Chemistry
- Vol. 193, 121-127
ePlantLIBRA: A composition and biological activity database for bioactive compounds in plant food supplements
- 23 March 2015
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 79 (4) , 578-592
Adverse effects of plant food supplements and botanical preparations: a systematic review with critical evaluation of causality
Aims: The objective of this review was to collect available data on the following: (i) adverse effects observed in humans from the intake of plant food supplements or botanical preparations; (ii) the misidentification of poisonous plants; and (iii) interactions between plant food supplements/botanicals and conventional drugs or nutrients.Methods: PubMed/MEDLINE and Embase were searched from database inception to June 2014, using the terms ‘adverse effect/s’, ‘poisoning/s’, ‘plant food supplement/s’, ‘misidentification/s’ and ‘interaction/s’ in combination with the relevant plant name. All papers were critically evaluated according to the World Health Organization Guidelines for causality assessment.Results: Data were obtained for 66 plants that are common ingredients of plant food supplements; of the 492 papers selected, 402 (81.7%) dealt with adverse effects directly associated with the botanical and 89 (18.1%) concerned interactions with conventional drugs. Only one case was associated with misidentification. Adverse effects were reported for 39 of the 66 botanical substances searched. Of the total references, 86.6% were associated with 14 plants, including Glycine max/soybean (19.3%), Glycyrrhiza glabra/liquorice (12.2%), Camellia sinensis/green tea ( 8.7%) and Ginkgo biloba/gingko (8.5%).Conclusions: Considering the length of time examined and the number of plants included in the review, it is remarkable that: (i) the adverse effects due to botanical ingredients were relatively infrequent, if assessed for causality; and (ii) the number of severe clinical reactions was very limited, but some fatal cases have been described. Data presented in this review were assessed for quality in order to make the results maximally useful for clinicians in identifying or excluding deleterious effects of botanicals.
- 23 March 2015
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 79 (4) , 578-592
Adverse effects of plant food supplements and botanical preparations: a systematic review with critical evaluation of causality
Aims: The objective of this review was to collect available data on the following: (i) adverse effects observed in humans from the intake of plant food supplements or botanical preparations; (ii) the misidentification of poisonous plants; and (iii) interactions between plant food supplements/botanicals and conventional drugs or nutrients.Methods: PubMed/MEDLINE and Embase were searched from database inception to June 2014, using the terms ‘adverse effect/s’, ‘poisoning/s’, ‘plant food supplement/s’, ‘misidentification/s’ and ‘interaction/s’ in combination with the relevant plant name. All papers were critically evaluated according to the World Health Organization Guidelines for causality assessment.Results: Data were obtained for 66 plants that are common ingredients of plant food supplements; of the 492 papers selected, 402 (81.7%) dealt with adverse effects directly associated with the botanical and 89 (18.1%) concerned interactions with conventional drugs. Only one case was associated with misidentification. Adverse effects were reported for 39 of the 66 botanical substances searched. Of the total references, 86.6% were associated with 14 plants, including Glycine max/soybean (19.3%), Glycyrrhiza glabra/liquorice (12.2%), Camellia sinensis/green tea ( 8.7%) and Ginkgo biloba/gingko (8.5%).Conclusions: Considering the length of time examined and the number of plants included in the review, it is remarkable that: (i) the adverse effects due to botanical ingredients were relatively infrequent, if assessed for causality; and (ii) the number of severe clinical reactions was very limited, but some fatal cases have been described. Data presented in this review were assessed for quality in order to make the results maximally useful for clinicians in identifying or excluding deleterious effects of botanicals.